Michael Rowe
Chief Executive Officer bei EYENOVIA, INC.
Vermögen: - $ am 31.03.2024
Profil
Michael M.
Rowe is currently the Chief Executive Officer & Director at Eyenovia, Inc. He previously worked as the Senior Vice President-Global Marketing at Gene Express, Inc. From 2016 to 2018, he was the Head-Global Strategic Marketing at Aerie Pharmaceuticals, Inc. Prior to that, he held the position of Head-Corporate Competitive Intelligence at Allergan Ltd.
(Ireland) from 2010 to 2016.
Mr. Rowe completed his undergraduate degree at Stony Brook University and his graduate degree at Rensselaer Polytechnic Institute.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EYENOVIA, INC.
-.--% | 12.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Michael Rowe
| Unternehmen | Position | Beginn |
|---|---|---|
| EYENOVIA, INC. | Chief Executive Officer | 01.08.2022 |
Ehemalige bekannte Positionen von Michael Rowe
| Unternehmen | Position | Ende |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.06.2018 |
| ALLERGAN PLC | Corporate Officer/Principal | 01.02.2016 |
Gene Express, Inc.
 Gene Express, Inc. Miscellaneous Commercial ServicesCommercial Services Gene Express, Inc. provides research and development on molecular diagnostic products. It also provides genomic data to accelerate and enable drug and molecular diagnostic development. The company was founded in 1992 and is headquartered in Wilmington, NC. | Sales & Marketing | - |
Ausbildung von Michael Rowe
| Stony Brook University | Undergraduate Degree |
| Rensselaer Polytechnic Institute | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EYENOVIA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Gene Express, Inc.
Gene Express, Inc. Miscellaneous Commercial ServicesCommercial Services Gene Express, Inc. provides research and development on molecular diagnostic products. It also provides genomic data to accelerate and enable drug and molecular diagnostic development. The company was founded in 1992 and is headquartered in Wilmington, NC. | Commercial Services |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
